Liposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efficiency

scientific article published on January 2002

Liposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efficiency is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/107175402753413136
P698PubMed publication ID11839204

P2093author name stringCrispin R Dass
Mark A Burton
Todd L Walker
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectquality controlQ827792
P304page(s)11-18
P577publication date2002-01-01
P1433published inDrug DeliveryQ5308838
P1476titleLiposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efficiency
P478volume9

Reverse relations

cites work (P2860)
Q45887356Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy
Q37067695Cationic lipid-nanoceria hybrids, a novel nonviral vector-mediated gene delivery into mammalian cells: investigation of the cellular uptake mechanism.
Q40322028Cellular VPS4 is required for efficient entry and egress of budded virions of Autographa californica multiple nucleopolyhedrovirus
Q34634385Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo
Q40857715Design and characterization of a new peptide vector for short interfering RNA delivery
Q43245706Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation
Q37124981Gene therapy for osteosarcoma: steps towards clinical studies.
Q34640040Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.
Q35577528Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculature
Q37734273In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans
Q44619320Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin
Q35819354Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection
Q45879281Microsphere-liposome complexes protect adenoviral vectors from neutralising antibody without losses in transfection efficiency, in-vitro
Q36729884Multiple strategies for gene transfer, expression, knockdown, and chromatin influence in mammalian cell lines and transgenic animals
Q40508578Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
Q38957716Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
Q35547269RETRACTED: Polyethyleneimine-based gene therapy by inhalation
Q37380142Review: doxorubicin delivery systems based on chitosan for cancer therapy.
Q50453864Structure-delivery relationships of lysine-based gemini surfactants and their lipoplexes
Q39377914Synthesis and preliminary investigations of the siRNA delivery potential of novel, single-chain rigid cationic carotenoid lipids
Q35684069The effect of neutral helper lipids on the structure of cationic lipid monolayers

Search more.